(Q40684981)

22 September 2017

title

Current surfactant use in premature infants (English)

1 reference

22 September 2017

0 references

Suresh GK

1

1 reference

22 September 2017

Soll RF

series ordinal

2

1 reference

22 September 2017

publication date

1 September 2001

1 reference

22 September 2017

published in

Clinics in Perinatology

1 reference

22 September 2017

volume

28

1 reference

22 September 2017

issue

3

1 reference

22 September 2017

page(s)

671-694

1 reference

Long-term pulmonary consequences of respiratory distress syndrome in preterm infants treated with exogenous surfactant.

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970112-3

7 January 2021

Pumactant and poractant alfa for treatment of respiratory distress syndrome in neonates born at 25-29 weeks' gestation: a randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970112-3

7 January 2021

Lung volume and pulmonary blood flow measurements following exogenous surfactant

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970112-3

7 January 2021

Surfactant deficiency in hyaline membrane disease: the story of discovery.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970112-3

7 January 2021

Immunogenicity and immunomodulatory activity of bovine surfactant (SF-RI 1)

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970112-3

7 January 2021

Cerebral blood flow and plasma hypoxanthine in relation to surfactant treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970112-3

7 January 2021

Prophylaxis of respiratory distress syndrome by treatment with modified porcine surfactant at birth: a multicentre prospective randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970112-3

7 January 2021

Effect of single dose surfactant on pulmonary function.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970112-3

7 January 2021

Pulmonary mechanics and energetics in preterm infants who had respiratory distress syndrome treated with synthetic surfactant

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970112-3

7 January 2021

Therapeutic use of surfactant in neonatal respiratory distress syndrome. Correlation between pulmonary X-ray changes and clinical data.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970112-3

7 January 2021

Exosurf rescue surfactant improves high ventilation-perfusion mismatch in respiratory distress syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970112-3

7 January 2021

Manual ventilation with a few large breaths at birth compromises the therapeutic effect of subsequent surfactant replacement in immature lambs

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970112-3

7 January 2021

Comparison of Infasurf (calf lung surfactant extract) to Survanta (Beractant) in the treatment and prevention of respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970112-3

7 January 2021

Pulmonary haemodynamics after surfactant replacement in severe neonatal respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970112-3

7 January 2021

Ventilation-perfusion relationships in preterm infants after surfactant treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970112-3

7 January 2021

Chest position and pulmonary deposition of surfactant in surfactant depleted rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970112-3

7 January 2021

Pulmonary mechanics in ventilated preterm infants with respiratory distress syndrome after exogenous surfactant administration: a comparison between two surfactant preparations

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970112-3

7 January 2021

Findings on chest radiographs after prophylactic pulmonary surfactant treatment of premature infants

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970112-3

7 January 2021

Surface tension of lung extracts

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970112-3

7 January 2021

Factors influencing the clinical response to surfactant replacement therapy in babies with severe respiratory distress syndrome. Collaborative European Multicentre Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970112-3

7 January 2021

Double-blind, randomized trial of one versus three prophylactic doses of synthetic surfactant in 826 neonates weighing 700 to 1100 grams: effects on mortality rate. American Exosurf Neonatal Study Groups I and IIa

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970112-3

7 January 2021

Double-blind developmental evaluation at 1-year corrected age of 597 premature infants with birth weights from 500 to 1350 grams enrolled in three placebo-controlled trials of prophylactic synthetic surfactant. American Exosurf Neonatal Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970112-3

7 January 2021

Surfactant administration to the human fetus in utero: a new approach to prevention of neonatal respiratory distress syndrome (RDS)

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970112-3

7 January 2021

Double-blind 1-year follow-up of 1540 infants with respiratory distress syndrome randomized to rescue treatment with two doses of synthetic surfactant or air in four clinical trials. American and Canadian Exosurf Neonatal Study Groups.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970112-3

7 January 2021

Effects of exogenous surfactant therapy on dynamic compliance during mechanical breathing in preterm infants with hyaline membrane disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970112-3

7 January 2021

Pulmonary follow-up 2.5 years after a randomized, controlled, multiple dose bovine surfactant study of preterm newborn infants

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970112-3

7 January 2021

Cerebral blood flow velocity changes after rapid administration of surfactant

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970112-3

7 January 2021

The pulmonary surfactant system: biochemical and clinical aspects

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970112-3

7 January 2021

Comparative trial of artificial and natural surfactants in the treatment of respiratory distress syndrome of prematurity: experiences in a developing country

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970112-3

7 January 2021

Surfactant nebulization versus instillation during high frequency ventilation in surfactant-deficient rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970112-3

7 January 2021

Radiological changes after therapeutic use of surfactant in infants with respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970112-3

7 January 2021

Changing mortality and causes of death in infants 23-27 weeks' gestational age.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970112-3

7 January 2021

Cerebral hemodynamic effects of treatment with modified natural surfactant investigated by near infrared spectroscopy.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970112-3

7 January 2021

Surfactant aerosol treatment of respiratory distress syndrome in the spontaneously breathing premature rabbit

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970112-3

7 January 2021

From bubbles to babies: the evolution of surfactant replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970112-3

7 January 2021

Effects of surfactant therapy on outcome of infants with birth weights of 600 to 750 grams

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970112-3

7 January 2021

Lysis of red blood cells and alveolar epithelial toxicity by therapeutic pulmonary surfactants

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970112-3

7 January 2021

Nebulisation of surfactants in an animal model of neonatal respiratory distress

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970112-3

7 January 2021

Artificial surfactant therapy in hyaline-membrane disease

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970112-3

7 January 2021

Clinical events in association with timing of intraventricular hemorrhage in preterm infants

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970112-3

7 January 2021

Pulmonary function at school-age in surfactant-treated preterm infants.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970112-3

7 January 2021

Early versus late surfactant treatment in preterm infants of 27 to 32 weeks' gestational age: a multicenter controlled clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970112-3

7 January 2021

Pulmonary surfactant in health and human lung diseases: state of the art.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970112-3

7 January 2021

Surface tension as a factor in the resistance of neonatal lungs to aeration.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970112-3

7 January 2021

Acute effects of instillation of surfactant in severe respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970112-3

7 January 2021

Exogenous human surfactant for treatment of severe respiratory distress syndrome: a randomized prospective clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970112-3

7 January 2021

A theoretical study of surfactant and liquid delivery into the lung.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970112-3

7 January 2021

Changes in pulmonary artery pressure in infants with respiratory distress syndrome following treatment with Exosurf

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970112-3

7 January 2021

Changes in pulmonary artery pressure during the acute phase of respiratory distress syndrome treated with three different types of surfactant

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970112-3

7 January 2021

The influence of the wider use of surfactant therapy on neonatal mortality among blacks and whites.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970112-3

7 January 2021

Factors influencing morbidity and mortality in infants with severe respiratory distress syndrome treated with single or multiple doses of a natural porcine surfactant.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970112-3

7 January 2021

Effects of surfactant therapy on outcome of extremely premature infants

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970112-3

7 January 2021

A European multicenter randomized controlled trial of single dose surfactant therapy for idiopathic respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970112-3

7 January 2021

A multicenter randomized trial comparing two surfactants for the treatment of neonatal respiratory distress syndrome. National Institute of Child Health and Human Development Neonatal Research Network

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970112-3

7 January 2021

A multicenter randomized, masked comparison trial of natural versus synthetic surfactant for the treatment of respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970112-3

7 January 2021

Effects of ventilation style on surfactant metabolism and treatment response in preterm lambs

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970112-3

7 January 2021

Pulmonary surfactant therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970112-3

7 January 2021

Mechanisms initiating lung injury in the preterm

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970112-3

7 January 2021

Surfactant metabolism.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970112-3

7 January 2021

Surfactant and pulmonary blood flow distributions following treatment of premature lambs with natural surfactant

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970112-3

7 January 2021

Pulmonary hemodynamics after synthetic surfactant replacement in neonatal respiratory distress syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970112-3

7 January 2021

High-versus low-threshold surfactant retreatment for neonatal respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970112-3

7 January 2021

A comparison of surfactant as immediate prophylaxis and as rescue therapy in newborns of less than 30 weeks' gestation

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970112-3

7 January 2021

Comparison of two strategies for surfactant prophylaxis in very premature infants: a multicenter randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970112-3

7 January 2021

Surfactant Replacement Therapy in Premature Babies with Respiratory Distress Syndrome: Factors Affecting the Response to Surfactant and Comparison of Outcome from 1982–86 and 1987–91

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970112-3

7 January 2021

A prospective, randomized trial of early versus late administration of a single dose of surfactant-TA

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970112-3

7 January 2021

Prognostic value of the immediate response to surfactant

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970112-3

7 January 2021

Trend in mortality from respiratory distress syndrome in the United States, 1970-1995

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970112-3

7 January 2021

Changes in EEG, systemic circulation and blood gas parameters following two or six aliquots of porcine surfactant

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970112-3

7 January 2021

Synthetic surfactant for rescue treatment of respiratory distress syndrome in premature infants weighing from 700 to 1350 grams: impact on hospital resource use and charges

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970112-3

7 January 2021

Randomized, placebo-controlled trial of human surfactant given at birth versus rescue administration in very low birth weight infants with lung immaturity

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970112-3

7 January 2021

Follow up of premature babies treated with artificial surfactant (ALEC).

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970112-3

7 January 2021

Cost implications of different approaches to the prevention of respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970112-3

7 January 2021

Outcome following pulmonary haemorrhage in very low birthweight neonates treated with surfactant

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970112-3

7 January 2021

Properties, Function and Origin of the Alveolar Lining Layer

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970112-3

7 January 2021

Effect of neonatal surfactant therapy on lung function at school age in children born very preterm

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970112-3

7 January 2021

In utero surfactant administration to preterm human fetuses using endoscopy

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970112-3

7 January 2021

Cost effects of surfactant therapy for neonatal respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970112-3

7 January 2021

Neonatal mortality rate: is further improvement possible?

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970112-3

7 January 2021

The role of surfactant-associated proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970112-3

7 January 2021

Pulmonary hemorrhage and exogenous surfactant therapy: a metaanalysis

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970112-3

7 January 2021

Racial differences in respiratory-related neonatal mortality among very low birth weight infants

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970112-3

7 January 2021

Different ventilation strategies alter surfactant responses in preterm rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970112-3

7 January 2021

A 2-year follow up of babies enrolled in a European multicentre trial of porcine surfactant replacement for severe neonatal respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970112-3

7 January 2021

Principles of surfactant replacement

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970112-3

7 January 2021

Comparison of clinical responses to natural and synthetic surfactants

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970112-3

7 January 2021

Surfactant replacement therapy improves ventilation inhomogeneity in infants with respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970112-3

7 January 2021

Effect of surfactant on morbidity, mortality, and resource use in newborn infants weighing 500 to 1500 g.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970112-3

7 January 2021

Surfactant Substitution in Ventilated Very Low Birth Weight Infants: Factors Related to Response Types

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970112-3

7 January 2021

Pulmonary distribution and efficacy of exogenous surfactant in lung-lavaged rabbits are influenced by the instillation technique

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970112-3

7 January 2021

Decreased surfactant dose-response after delayed administration to preterm rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970112-3

7 January 2021

One-year follow-up of 273 infants with birth weights of 700 to 1100 grams after prophylactic treatment of respiratory distress syndrome with synthetic surfactant or air placebo. American Exosurf Neonatal Study Group I

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970112-3

7 January 2021

Acute effects of synthetic surfactant replacement on pulmonary blood flow in neonatal respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970112-3

7 January 2021

Hemodynamic prediction of complications in neonatal respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970112-3

7 January 2021

School-age follow-up of prophylactic versus rescue surfactant trial: pulmonary, neurodevelopmental, and educational outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970112-3

7 January 2021

The effects of surfactant on haemodynamics in hyaline membrane disease

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970112-3

7 January 2021

Surfactant Administration and the Cerebral Circulation

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970112-3

7 January 2021

Acute changes in cerebral oxygenation and cerebral blood volume in preterm infants during surfactant treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970112-3

7 January 2021

Radiological analysis of hyaline membrane disease after exogenous surfactant treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970112-3

7 January 2021

A randomized comparison of surfactant dosing via a dual-lumen endotracheal tube in respiratory distress syndrome. The Spanish Surfactant Collaborative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970112-3

7 January 2021

A simplified surfactant dosing procedure in respiratory distress syndrome: the "side-hole" randomized study. Spanish Surfactant Collaborative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970112-3

7 January 2021

Natural surfactant extract versus synthetic surfactant for neonatal respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970112-3

7 January 2021

Prophylactic versus selective use of surfactant for preventing morbidity and mortality in preterm infants

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970112-3

7 January 2021

Surfactant treatment of the very preterm infant

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970112-3

7 January 2021

Radiographic findings associated with surfactant treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970112-3

7 January 2021

Cost effectiveness of beractant in the prevention of respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970112-3

7 January 2021

Randomised clinical trial of two treatment regimens of natural surfactant preparations in neonatal respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970112-3

7 January 2021

Pulmonary hemorrhage: clinical course and outcomes among very low-birth-weight infants

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970112-3

7 January 2021

Cost of surfactant replacement treatment for severe neonatal respiratory distress syndrome: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970112-3

7 January 2021

Distribution of surfactant and ventilation in surfactant-treated preterm lambs

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970112-3

7 January 2021

Outcome at twelve months of adjusted age in very low birth weight infants with lung immaturity: a randomized, placebo-controlled trial of human surfactant

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970112-3

7 January 2021

Prediction of the acute response to surfactant therapy by pulmonary function testing

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970112-3

7 January 2021

Pulmonary functional outcome at one year of age in infants treated with natural porcine surfactant at birth.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970112-3

7 January 2021

Porcine surfactant replacement therapy in newborns of 25-31 weeks' gestation: a randomized, multicentre trial of prophylaxis versus rescue with multiple low doses. The French Collaborative Multicentre Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970112-3

7 January 2021

Porcine-derived lung surfactant. A review of the therapeutic efficacy and clinical tolerability of a natural surfactant preparation (Curosurf) in neonatal respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970112-3

7 January 2021

Respiratory function at follow-up after neonatal surfactant replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970112-3

7 January 2021

Comparison of three dosing procedures for administration of bovine surfactant to neonates with respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970112-3

7 January 2021

10.1016/S0095-5108(05)70112-3

Identifiers

DOI

1 reference

22 September 2017

1 reference